(RTTNews) - Iovance Biotherapeutics (IOVA), a biotechnology company, on Thursday announced the appointment of Noah Berkowitz as Chief Medical Officer, effective September 30.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.